Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study

INTRODUCTION: Switching therapy studies are usually designed as second-line antiretroviral treatment (ART) in patients without previous virologic failures. Combined ART (cART) with DRV/r and ETR has a good pharmacokinetic profile, high genetic barrier and has been proved as rescue therapy. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Portilla, Joaquín, Arazo, Piedad, Crusells, Josefa, Pérez-Martínez, Laura, Martínez-Madrid, Onofre, Boix, Vicente, Moreno, Javier, Navarro, Vicente, Rubio, Teresa, Reus, Sergio, Galera, Carlos, Bernal, Enrique, Jover, Francisco, Amador, Concepcion, Baño, David, Merino, Esperanza, Saiz-de-la-Hoya, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P271
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225347/
https://www.ncbi.nlm.nih.gov/pubmed/25397547
http://dx.doi.org/10.7448/IAS.17.4.19803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225347/
https://www.ncbi.nlm.nih.gov/pubmed/25397547
http://dx.doi.org/10.7448/IAS.17.4.19803

Ejemplares similares